Keep in touch with meI'm using Intch to connect with new people. Use this link to open chat with me via Intch app
Work Background
Gilead SciencesAssociate Director HCV Marketing, Direct to Consumer/Patient
Aug. 2022 - Nov. 2023
Dynavax TechnologiesAssociate Director, Marketing
Mar. 2021 - Aug. 2022San Francisco Bay Area
Dynavax TechnologiesSenior Marketing Manager
Aug. 2019 - Mar. 2021San Francisco Bay Area
Big HealthMarketing and Partnerships Manager
May. 2018 - May. 2019San Francisco Bay Area
PaxVax, Inc.Marketing Manager
Jan. 2017 - Jun. 2018San Francisco Bay Area(acquired by Emergent Biosolutions Inc.) PaxVax develops, manufactures and commercializes innovative specialty vaccines against infectious diseases for traditionally overlooked markets such as travel. PaxVax has licensed vaccines for typhoid fever (Vivotif) and cholera (Vaxchora), and vaccines at various stages of research and clinical development for adenovirus, anthrax, hepatitis A, HIV, and zika. As part of its social mission, PaxVax is also working to make its vaccines available to broader populations most affected by these diseases. PaxVax is headquartered in Redwood City, California and maintains research and development and Good Manufacturing Practice (GMP) facilities in San Diego, California and Bern, Switzerland and other operations in Bermuda and Europe. More information is available at www.PaxVax.com.